On the other hand, NfL has been used as a marker of neuroaxonal injury in amyotrophic lateral sclerosis, frontotemporal dementia, and multiple sclerosis, although, currently, it appears to be a marker of neurodegeneration in neurodegenerative dementias [41,42], including AD. This evidence concerns the gene NEFL and Alzheimer disease.